COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Study of the Safety and Antiretroviral Activity of 3BNC117

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02588586
Recruitment Status : Completed
First Posted : October 28, 2015
Last Update Posted : April 30, 2019
National Institute of Allergy and Infectious Diseases (NIAID)
Bill and Melinda Gates Foundation
Weill Medical College of Cornell University
Montefiore Medical Center
Information provided by (Responsible Party):
Marina Caskey, MD, Rockefeller University

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 2018
Actual Study Completion Date : April 2018
Certification/Extension First Submitted : April 16, 2019